Status of group B streptococcal vaccine development

Streptococcus agalactiae (group B streptococcus, GBS) is a leading causal organism of neonatal invasive diseases and severe infections in the elderly. Despite significant advances in the diagnosis and treatment of GBS infections and improvement in personal hygiene standards, this pathogen is still a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shun Mei, Zhi, Yong, Ahn, Ki Bum, Lim, Sangyong, Seo, Ho Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795048/
https://www.ncbi.nlm.nih.gov/pubmed/29399583
http://dx.doi.org/10.7774/cevr.2018.7.1.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795048/
https://www.ncbi.nlm.nih.gov/pubmed/29399583
http://dx.doi.org/10.7774/cevr.2018.7.1.76

Ejemplares similares